Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04462107 · ClinicalTrials.gov registry record
Longitudinal Study Evaluating Recovery After Scheduled Cesarean Delivery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 66
- Enrollment target
NCT04462107: Completed study, sponsored by Mayo Clinic.
NCT04462107 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04462107 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The purpose of this research is to describe how patients recover after scheduled C-section for the first 3 months.
Primary Outcome
Global health on a scale of 0-100 to indicate current health status with 0 being the worst imaginable health and 100 being the best health imaginable. Plan was to identify the plateau of improvement of GHVAS postpartum.
Interventions
- OTHER Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-11-01 |
What the finished NCT04462107 record still lists
NCT04462107 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Surveys is the first listed.
NCT04462107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04462107 about?
NCT04462107 is a clinical study titled "Longitudinal Study Evaluating Recovery After Scheduled Cesarean Delivery". The purpose of this research is to describe how patients recover after scheduled C-section for the first 3 months.
What is the current status of trial NCT04462107?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2021-02-01. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04462107?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT04462107?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI